publication venue for
- Vesicular stomatitis virus infects and kills human leukemic cells while sparing normal bone marrow progenitors. 2001
- Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. 21:984-990. 2014
- Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes. 20:24-34. 2013
- Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model. 19:355-364. 2012
- The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models. 18:1157-1165. 2011
- Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model. 18:986-995. 2011
- Pre-clinical evaluation of liposomal gene transfer to improve dermal and epidermal regeneration. 17:770-778. 2010
- PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses. 16:1077-1087. 2009
- The combination of IGF-I and KGF cDNA improves dermal and epidermal regeneration by increased VEGF expression and neovascularization. 14:1235-1242. 2007
- Gene therapy in wound healing: present status and future directions. 14:1-10. 2007
- Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. 13:1657-1664. 2006
- The structure and composition of liposomes can affect skin regeneration, morphology and growth factor expression in acute wounds. 12:1718-1724. 2005
- Liposomal gene transfer of multiple genes is more effective than gene transfer of a single gene. 11:847-855. 2004
- Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors. 11:504-511. 2004
- Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. 10:1494-1502. 2003
- Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. 10:251-260. 2003
- Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors. 9:1065-1074. 2002
- Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth. 9:898-905. 2002
- Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent. 8:1777-1784. 2001
- Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. 8:282-290. 2001
- Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12. 8:316-323. 2001
- Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. 7:1840-1846. 2000
- Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons. 7:1200-1209. 2000
- Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. 6:1565-1573. 1999
- Adenoviral vectors: prospects for gene delivery to the central nervous system. 6:1349-1350. 1999
- IGF-I gene transfer in thermally injured rats. 6:1015-1020. 1999
- Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury. 6:573-584. 1999
- Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. 6:350-363. 1999
- Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors. 5:1400-1409. 1998
- Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. 5:352-360. 1998
- Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging. 4:1371-1378. 1997
- Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα. 4:1181-1188. 1997
- Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. 4:1069-1076. 1997
- In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer. 4:442-448. 1997
- Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. 4:140-149. 1997